Clinical Trial Update: Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of EVO101 topical cream in Atopic Dermatitis has completed and results have been posted. Sponsor: Evommune, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• EVO101 Topical Cream (EVO101)

Snippet

Sponsor: Evommune, Inc. | Conditions: Atopic Dermatitis Eczema | Phase 2 | Status: COMPLETED | Results posted: 2025-03-05